Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
2-(4-Pyridyl)-4-methyl-thiazole-5-carboxylic acid is a synthetic intermediate that serves as a crucial building block in pharmaceutical synthesis. This compound enhances the development of complex drug molecules, facilitating various biological activities. Its unique structure makes it valuable for research in medicinal chemistry and the design of novel therapeutic agents. -
Drug Impurity
(S)-Tamsulosin hydrochloride is a chiral impurity associated with the pharmaceutical compound tamsulosin, primarily targeting alpha-1 adrenergic receptors. This reagent may serve a critical role in the analytical characterization and quality control of tamsulosin formulations. Its presence can impact the pharmacological profile and efficacy of the drug, making it an essential component for research and development in pharmaceutical sciences. -
Drug Impurity
Acebutolol impurity 7 is a secondary compound generated during the synthesis of Acebutolol, a selective beta-1 adrenergic receptor blocker. This reagent is primarily utilized in drug development and quality control to ensure the purity and safety of pharmaceutical formulations. Its characterization and analysis are essential for compliance with regulatory standards in chemical research and formulation studies. -
Drug Impurity
Rivaroxaban Impurity 19 is a chemical impurity associated with the anticoagulant Rivaroxaban. It serves as a useful reference standard for quality control and analytical testing in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of Rivaroxaban formulations, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Dabigatran impurity 75 is a chemical impurity associated with the anticoagulant drug Dabigatran. This compound is critical for quality control and characterization in pharmaceutical research, particularly during the assessment of drug purity and compliance with regulatory standards. Its analysis aids in the understanding of the pharmacological profile and safety of Dabigatran formulations, essential for developing and validating drug manufacturing processes. -
Drug Impurity
Rosuvastatin impurity 29 is a identified impurity of the cholesterol-lowering agent, Rosuvastatin. This compound serves as an important indicator for quality control and validation in pharmaceutical formulations. Its characterization is essential for ensuring the safety and efficacy of Rosuvastatin products in clinical research and development. -
Drug Impurity
Mesalazine impurity 5 is a known impurity associated with the anti-inflammatory drug Mesalazine. This compound serves as a critical standard for analytical chemistry, particularly in the quality control and validation of pharmaceutical formulations. Its presence can impact the safety and efficacy of Mesalazine, making it essential for research in drug development and regulatory compliance. -
Drug Impurity
Axitinib Impurity 7 is a chemical reagent associated with the anticancer drug Axitinib. As a drug impurity, it serves as a valuable reference standard for analytical and stability studies. It is essential in the evaluation of the purity, efficacy, and safety of Axitinib formulations in pharmaceutical research. This compound is instrumental in ensuring compliance with regulatory guidelines and conducting thorough quality control assessments. -
Drug Impurity
Meloxicam impurity 5 is an identified impurity of the non-steroidal anti-inflammatory drug (NSAID) Meloxicam. This compound can serve as a reference standard in the analysis of drug formulations and for quality control purposes. Its study can provide insights into the stability, safety, and impurity profiling of pharmaceuticals containing Meloxicam. This impurity is critical for researchers focused on optimizing drug quality and regulatory compliance. -
Drug Impurity
Montelukast impurity 8 is a chemical impurity associated with Montelukast, a leukotriene receptor antagonist used primarily in the management of asthma and allergic rhinitis. This impurity is relevant for method development and validation in pharmaceutical quality control, as well as stability studies and impurity profiling in drug formulation research. Its study aids in understanding the potential effects of impurities on drug safety and efficacy. -
Drug Impurity
Estradiol benzoate impurity 3 is a chemical impurity associated with Estradiol benzoate. This compound serves as a reference standard for quality control and analytical studies involving estradiol formulations. Its identification is essential for ensuring the purity and reliability of estradiol-related products in pharmaceutical research and development. -
Drug Impurity
Prednisolone Impurity 8, also known as Prednisolone 11,21-Diacetate, is a chemical impurity associated with the steroid medication Prednisolone. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. This reagent is used to confirm the purity and identity of Prednisolone formulations, assisting in studies related to drug efficacy and safety. -
Drug Impurity
Quetiapine impurity 5 is identified as an impurity associated with the antipsychotic drug Quetiapine. This compound may be utilized in analytical studies to assess the purity of Quetiapine formulations and to investigate potential pharmacological effects related to its impurities. Its characterization is essential for ensuring the quality and safety of pharmaceutical products containing Quetiapine. -
Drug Impurity
Aceclofenac impurity 1 (Diacetic aceclofenac) is identified as an impurity of Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID). This compound is utilized primarily in the quality control and characterization of pharmaceutical formulations containing Aceclofenac. Its presence and concentration can significantly impact the efficacy and safety profile of the final drug product, making it relevant in pharmacokinetic and toxicological studies. -
Drug Impurity
Donepezil impurity 2, also known as Donepezil benzyl bromide, is a notable impurity of Donepezil utilized in pharmaceutical research. Its primary significance lies in drug development and analytical chemistry, where it serves as a reference standard for quality control and impurity profiling. Researchers can employ this compound to ensure the purity and safety of Donepezil formulations, aiding in compliance with regulatory standards. -
Drug Impurity
11-Keto Budesonide is a metabolite of Budesonide, primarily functioning as a drug impurity. It is involved in pharmacokinetic studies and can provide insights into drug metabolism and elimination pathways. Researchers utilize this compound to better understand the stability and degradation of steroid compounds in pharmaceutical formulations. -
Drug Impurity
Methylprednisolone impurity 6 is a recognized impurity associated with Methylprednisolone, a corticosteroid with glucocorticoid properties. This impurity is significant for research related to drug formulation, stability testing, and quality control within pharmaceutical development. It serves as a critical reference for assessing the purity and efficacy of corticosteroid preparations. -
Drug Impurity
Iguratimod impurity 1 is a chemical impurity associated with Iguratimod, which primarily functions as a modulator of the immune response. It is utilized in research to understand the safety, efficacy, and pharmacokinetics of Iguratimod and related compounds. This impurity can support studies on the compound's stability and formulation development in therapeutic applications. -
Drug Impurity
Rosuvastatin Impurity 4, also known as 3-Oxo rosuvastatin, is a chemical impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound is significant for analytical and quality control purposes in pharmaceutical research, particularly in assessing the purity and efficacy of Rosuvastatin formulations. Its characterization aids in understanding degradation pathways and improving the overall drug development process. -
Dexamethasone Impurity
17β-Carboxy-17-desoxydexamethasone is an impurity of dexamethasone, a synthetic glucocorticoid commonly used in therapeutic settings. It serves as a critical reference standard for purity assessment and quality control in dexamethasone formulations. Researchers may utilize this compound to evaluate the stability and degradation pathways of glucocorticoid compounds in pharmaceutical development. -
Drug Impurity
Betamethasone dipropionate impurity 5 is a known impurity of the corticosteroid betamethasone dipropionate. This compound is primarily utilized in the assessment of drug purity and quality control within pharmaceutical formulations. Its characterization is essential for ensuring the safety and efficacy of drug products containing betamethasone dipropionate. Research applications include analytical techniques such as HPLC and mass spectrometry for impurity profiling. -
Drug Impurity
Candesartan impurity 2 is a specified drug impurity associated with the angiotensin II receptor antagonist Candesartan. It is utilized primarily in analytical chemistry for impurity profiling and method validation within pharmaceutical development. Understanding the presence of such impurities is crucial for ensuring the safety and efficacy of pharmaceutical formulations. -
Drug Intermediate
3-Thio-pheneacrylic acid methyl ester is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a key building block in the development of various drug candidates, facilitating the incorporation of thio-containing functionalities into target molecules. Its unique chemical structure allows for versatility in medicinal chemistry applications, contributing to the advancement of therapeutic agents. -
Drug Impurity
Propofol impurity 3 is a chemical impurity associated with the anesthetic agent Propofol. This impurity can be utilized in quality control and analytical chemistry to ensure the purity of Propofol formulations. Its characterization is essential for understanding the stability and safety profiles of Propofol in therapeutic contexts. -
Drug Impurity
Abiraterone impurity 1 is a recognized impurity associated with the drug Abiraterone, an inhibitor of cytochrome P450 17A1, primarily used in the treatment of prostate cancer. This chemical research reagent is critical for quality control and analytical assessment during the synthesis and formulation of Abiraterone. Its presence can impact the efficacy and safety profile of the final pharmaceutical product, making it essential for thorough characterizations in drug development. -
Drug Impurity
Apixaban impurity 21 is a chemical impurity associated with the anticoagulant apixaban, which primarily targets factor Xa in the coagulation cascade. This impurity can be utilized in the quality control and characterization of apixaban formulations, aiding in the assessment of compound purity and stability. Its presence may affect the pharmacological profile of apixaban and can be relevant in pharmacokinetic studies. -
Impurity reference
S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin calcium is characterized as an impurity reference for the statin drug rosuvastatin. This compound serves as a critical analytical standard in the evaluation of pharmaceutical formulations and quality control processes. It plays an essential role in ensuring the purity and compliance of rosuvastatin products in research and development settings. -
Drug Impurity
Alfuzosin EP impurity 3, also known as deacylated alfuzosin, represents a key impurity associated with the pharmacological agent alfuzosin. This compound may be utilized in analytical studies to assess the purity and quality of alfuzosin formulations. Its presence can significantly impact the efficacy and safety profiles of related pharmaceutical products, making it relevant for researchers focused on drug development and quality control. -
Drug Impurity
Sitagliptin impurity 8 phosphate is a recognized impurity associated with the phosphoric acid derivative of Sitagliptin. This compound serves as a critical analytical standard in the characterization and quality control of Sitagliptin phosphate formulations. It is valuable for researchers involved in drug development and pharmacokinetic studies, ensuring the integrity and purity of Sitagliptin products. -
Drug Impurity
Estradiol Valerate impurity 2 is a chemical impurity associated with Estradiol Valerate, a synthetic form of estrogen. This compound is utilized in the evaluation of drug purity and quality control processes in pharmaceutical research. Its presence may impact the pharmacological activity and safety profile of estradiol formulations, making it essential for thorough analytical studies. -
Drug Impurity
Sertraline impurity 1 hydrochloride is a recognized impurity associated with Sertraline hydrochloride, a selective serotonin reuptake inhibitor (SSRI). This compound is essential for analytical purposes in drug development and quality control, as it aids in the identification and quantification of impurities in pharmaceutical formulations. Researchers can utilize Sertraline impurity 1 hydrochloride to enhance the understanding of drug stability and efficacy in various biochemical assays. -
Drug Impurity
Olmesartan methyl ketone is an impurity of the antihypertensive agent Olmesartan. It is commonly utilized in the analysis of drug formulations to assess purity and ensure compliance with regulatory standards. The presence of this impurity can be monitored to evaluate the quality of pharmaceutical products during research and development. -
Chlorhexidine impurity
Chlorhexidine impurity 1 is an impurity associated with the cationic antimicrobial agent chlorhexidine, which primarily disrupts microbial cell membranes. This compound may be utilized in research concerning the purity and characterization of chlorhexidine formulations, as well as studies examining its antimicrobial activity and efficacy. Further investigation into this impurity can provide insights into the overall safety and effectiveness of chlorhexidine in various applications. -
Drug Impurity
Fusidic acid impurity 4 is a known impurity associated with Fusidic acid. This compound can be utilized in the assessment of drug purity and quality control in pharmaceutical formulations. It plays a critical role in research applications focused on the synthesis and characterization of pharmacologically active compounds, ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Dexmedetomidine impurity 2 is a chemical impurity related to Dexmedetomidine, a selective alpha-2 adrenergic receptor agonist. This impurity is significant in assessing the purity and quality of Dexmedetomidine formulations. It is utilized primarily in analytical chemistry and pharmaceutical development, particularly for the evaluation of drug substances and ensuring compliance with regulatory standards. -
Drug Impurity
Albendazole impurity 1 is a recognized impurity associated with the antiparasitic drug Albendazole. This compound serves as a vital standard for analytical characterization and quality control in pharmaceutical research. Its presence may influence the efficacy and safety assessment of Albendazole formulations, making it essential for investigative studies focused on drug purity and drug development processes. -
Drug Impurity
Rosuvastatin impurity 32 is a chemical impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound can be used for analytical purposes in drug quality control, pharmacokinetic studies, and formulation development. Its presence in formulations may impact efficacy and safety profiles, making it essential for researchers examining the purity and stability of Rosuvastatin-based therapies. -
Drug Impurity
Trazodone impurity 3 is a known impurity associated with the antidepressant Trazodone. This compound serves as a reference standard in quality control and method development for pharmaceutical formulations. Its analysis is crucial for ensuring the purity and safety of Trazodone products in clinical and research settings. -
Drug Impurity
Dabigatran impurity 4 is a known impurity of the anticoagulant Dabigatran, functioning as a direct thrombin inhibitor. This reagent is primarily used in the assessment of drug purity, stability, and validation processes in pharmaceutical research. Its presence and characterization are critical for ensuring the quality and safety of Dabigatran formulations in clinical applications. -
Drug Impurity
Donepezil impurity 16 is a known impurity of the cholinesterase inhibitor Donepezil, primarily targeting acetylcholinesterase. This compound is utilized in research to ensure the quality and consistency of Donepezil formulations. Its analysis is critical for assessing drug safety and efficacy in pharmaceutical development. -
Drug Impurity
Buspirone EP impurity J is an identified impurity of the anxiolytic agent Buspirone. This compound is utilized primarily in pharmaceutical research to assess the purity and safety of Buspirone formulations. Its analysis is crucial for regulatory compliance and the development of quality control measures in drug manufacturing. -
Drug Impurity
Fenirofibrate impurity 1 is a known impurity associated with Fenirofibrate. Its identification is essential for quality control and regulatory compliance in pharmaceutical formulations. This compound can be utilized in analytical studies to assess the purity of Fenirofibrate and ensure the integrity of drug products in development and production. -
Drug Impurity
Acyclovir impurity 10 is a specific impurity related to the antiviral agent Acyclovir, primarily targeting viral DNA replication processes. This reagent is crucial for quality control and analytical studies in pharmaceutical research, enabling the assessment of Acyclovir's purity and safety. It is often utilized in the development and validation of analytical methods, contributing to the understanding of impurity profiles in drug formulation. -
Drug Impurity
Everolimus impurity 13 is a notable impurity of the immunosuppressant drug Everolimus. It is utilized primarily for analytical purposes in pharmaceutical research to assess the purity and quality of Everolimus formulations. This compound aids in the development of rigorous quality control methods and contributes to the comprehensive understanding of drug stability and degradation pathways in pharmaceutical sciences. -
Drug Impurity
Ibuprofen impurity 5, also known as Ibuprofen impurity I, is a chemical impurity associated with Ibuprofen. This compound can be utilized in drug formulation studies and analytical chemistry to assess the purity and stability of Ibuprofen formulations. Understanding and monitoring impurities is critical for ensuring the safety and efficacy of pharmaceutical products in research and development settings. -
Drug Impurity
Rufinamide impurity 8 is a known impurity of the anticonvulsant agent Rufinamide. This compound is primarily utilized in the analysis of drug purity and quality control in pharmaceutical research. It serves as an important tool for understanding the stability and degradation pathways of Rufinamide, ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Rosuvastatin impurity 42 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin, primarily targeting HMG-CoA reductase. This compound is critical for quality control in pharmaceutical development and analytical studies to ensure the purity and safety of Rosuvastatin formulations. Research applications include method validation, stability testing, and impurity profiling in drug development processes. -
Naphazoline Impurity
N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide is an impurity associated with Naphazoline. This compound can serve as a reference standard in analytical chemistry for the quality control of Naphazoline formulations. Its identification and quantification are crucial for ensuring the purity and efficacy of pharmaceutical preparations containing Naphazoline. -
Drug Impurity
Clopidogrel impurity 4, known as R-Clopidogrel carboxylic acid, is a recognized impurity of the antiplatelet agent Clopidogrel. This compound is utilized in analytical chemistry and pharmacological research to evaluate the purity and stability of Clopidogrel formulations. Its characterization is essential for regulatory compliance and ensuring the safety and efficacy of Clopidogrel-based therapies. -
Drug Impurity
Etoricoxib impurity 17 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Etoricoxib, which selectively targets cyclooxygenase enzymes (COX-2). This compound is relevant for research concerning drug purity and quality control, particularly in the pharmaceutical development of Etoricoxib. Analysis of this impurity may help in understanding the metabolic pathways and stability profiles of NSAIDs in clinical formulations.
